CAC Software vs Zio ECG Utilization Software (ZEUS) System

Loosely related. A direct comparison may be less useful — each tool solves a different problem. Comparability 40/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CAC Software

by 4DMedical (Imbio CAC Software)

ZEUS System

by iRhythm Technologies, Inc.

AI Verdict

Tool A, Imbio's CAC Software, analyzes non-contrast chest CT scans to quantify coronary artery calcification for cardiovascular risk assessment. Tool B, iRhythm's ZEUS System, analyzes continuous ECG data from wearable monitors to detect and classify cardiac arrhythmias. While both are cardiology AI tools, their input data, analytical methods, and specific diagnostic outputs are distinct, making them suitable for different clinical questions related to heart health.

Choose CAC Software if…

Choose Imbio's CAC Software if your primary goal is to assess a patient's risk for coronary artery disease by quantifying calcification within their coronary arteries. This tool is ideal for radiologists and cardiologists analyzing non-contrast chest CT scans to generate precise Agatston scores, arterial age, and 3D visualizations for comprehensive risk stratification.

View CAC Software →

Choose ZEUS System if…

Choose iRhythm Technologies' Zio ECG Utilization Software (ZEUS) System if you require continuous, long-term monitoring and AI-powered analysis of ECG data to diagnose and manage cardiac arrhythmias. This cloud-based platform is best suited for physicians seeking detailed arrhythmia detection and classification from wearable Zio monitors, providing comprehensive end-of-wear reports for patient care.

View ZEUS System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CAC Software	ZEUS System
Pricing	Unknown	Not disclosed
Deployment	Cloud-based (SaaS), integrates with PACS	Cloud-based (AWS EC2 platform), no on-premise hardware.
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ZEUS System

Tool B (Zio ECG Utilization Software) offers a more comprehensive and user-friendly experience for both patients and clinicians. It includes a wearable monitor, a patient-facing mobile app (MyZio) for symptom logging, and a clinician portal (ZioSuite) with a mobile app for managing workflows. Tool A (CAC Software) is primarily an automated image post-processing tool that integrates into existing PACS workflows, with minimal direct user interaction beyond reviewing reports.

Clinical Value

ZEUS System

Tool B (Zio ECG Utilization Software) has extensive clinical validation demonstrating higher arrhythmia detection rates and lower retesting rates compared to traditional methods, with over 8 million patients served. Tool A (CAC Software) provides valuable quantitative risk assessment for coronary artery disease from CT scans, which is clinically significant, but Tool B's impact on diagnosis and management of cardiac arrhythmias across a large patient base appears to offer broader clinical value.

Pricing & Value

Tie

Both tools operate on a Software as a Service (SaaS) model, but neither provides public pricing details. Without transparent pricing, it's difficult to assess which offers better value. Both aim to improve diagnostic efficiency and patient outcomes, which inherently provides value to healthcare systems.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness. Tool A (CAC Software) is cloud-based (SaaS) with PACS integration and offers on-premise deployment options, along with robust compliance (HIPAA, SOC2, GDPR). Tool B (Zio ECG Utilization Software) is also cloud-based, offers HL7-based EHR integration, and has served over 8 million patients, indicating scalability and reliability. Both are FDA-cleared and have necessary certifications.

Innovation

ZEUS System

Tool B (Zio ECG Utilization Software) demonstrates greater innovation through its end-to-end solution combining a wearable biosensor, AI-powered cloud analytics, and integrated patient and clinician platforms. This approach to continuous, long-term cardiac monitoring represents a significant advancement in arrhythmia detection. Tool A (CAC Software) offers innovative AI-powered quantification of coronary artery calcification from existing CT scans, but Tool B's integrated hardware-software-service model is arguably more disruptive.

Support & Docs

Tie

Both companies provide professional support for their respective products. Tool A (CAC Software) integrates into existing workflows and provides DICOM files and PDF reports, implying standard documentation for radiologists. Tool B (Zio ECG Utilization Software) offers educational resources and FAQs for patients and professionals. Without specific details on the breadth and depth of support and documentation for each, it's difficult to declare a definitive winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CAC Software	ZEUS System
Product Name	CAC Software	Zio ECG Utilization Software (ZEUS) System
Company	Imbio	iRhythm Technologies
Primary Function	Automated image post-processing for coronary artery calcification from non-contrast chest CT scans.	AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias.
Key Output/Analysis	Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations, annotated images.	AI algorithm for arrhythmia detection and classification, comprehensive end-of-wear reports.
Data Source/Input	Non-contrast, chest computed tomography (CT)	Continuous ECG data from wearable Zio monitors (Zio monitor, Zio Watch)

Videos

Demos, reviews, and walkthroughs featuring CAC Software and ZEUS System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of each tool?

Imbio's CAC Software (Tool A) is designed to help determine the location and amount of calcification within coronary arteries from non-contrast chest CT scans, supporting risk assessment for coronary artery disease. iRhythm's ZEUS System (Tool B) analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias.

What type of patient data do these tools analyze?

Tool A analyzes non-contrast chest computed tomography (CT) images to identify coronary artery calcification. Tool B analyzes continuous ECG data collected from wearable Zio monitors.

What specific outputs or reports do these tools provide?

Tool A outputs an Agatston score, arterial age, calcified lesion mass and volume, along with 3D visualizations and annotated images. Tool B provides comprehensive end-of-wear reports for physician review, based on its AI algorithm for arrhythmia detection and classification.

Which medical specialties are these tools primarily designed to support?

Tool A is primarily designed for cardiologists and radiologists. Tool B supports cardiologists, family medicine physicians, and internal medicine physicians.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring CAC Software or ZEUS System

Backers

Who funded each tool's parent company.